Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

If you have a question about this talk, please contact Sarah Noujaim.

 

Cardiac function depends on provision of blood-borne substrates to maintain adequate myocardial metabolism. Metabolic substrates vary in efficiency and energy yield, and the ability to flexibly switch between substrates according to varying pathophysiological states is key to maintaining adequate cardiac function. Cardiac utilisation of carbohydrate in the form of glucose, and lipid in the form of non-essential fatty acids, is well defined, but cardiac utilisation of triacylglycerols (triglycerides;  TAG ), a potentially large source of exogenous energy, has been harder to examine. Studies defining cardiac  TAG  utilisation in a variety of pathophysiological states, their selection preference and their contribution to cardiac function, will be discussed. Novel issues of routes of cardiac  TAG  uptake, and the potential role of  TAG -rich lipoproteins as metabolic signals, will also be discussed.